share_log

Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Pannu Geraldine

Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Pannu Geraldine

Processa Pharmaceuticals | 4:持股变动声明-董事 Pannu Geraldine
美股SEC公告 ·  09/18 16:53

Moomoo AI 已提取核心信息

Geraldine Pannu, a reporting person for Processa Pharmaceuticals, Inc. [PCSA], was involved in a transaction on 09/03/2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Pannu is associated with the company's headquarters in Hanover, MD. Without further transaction details, the impact on Pannu's holdings and the overall share distribution of Processa Pharmaceuticals remains unclear.
Geraldine Pannu, a reporting person for Processa Pharmaceuticals, Inc. [PCSA], was involved in a transaction on 09/03/2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Pannu is associated with the company's headquarters in Hanover, MD. Without further transaction details, the impact on Pannu's holdings and the overall share distribution of Processa Pharmaceuticals remains unclear.
Processa Pharmaceuticals的报告人Geraldine Pannu [PCSA]于2024年09月03日进行了一项交易。交易的具体细节,包括行动类型、状态、股份数量、股份性质、交易价格以及交易后的参股金融,在公告中没有披露。报告人Pannu提供的地址与公司总部位于MD州汉诺威市的地址相关联。没有进一步的交易细节,Pannu的持股情况以及Processa Pharmaceuticals的整体股权分布的影响仍不清楚。
Processa Pharmaceuticals的报告人Geraldine Pannu [PCSA]于2024年09月03日进行了一项交易。交易的具体细节,包括行动类型、状态、股份数量、股份性质、交易价格以及交易后的参股金融,在公告中没有披露。报告人Pannu提供的地址与公司总部位于MD州汉诺威市的地址相关联。没有进一步的交易细节,Pannu的持股情况以及Processa Pharmaceuticals的整体股权分布的影响仍不清楚。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息